25 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
and effort in the areas of training, record keeping, production and quality control.
After the FDA evaluates the NDA and the manufacturing facilities … to, special training or certification for prescribing or dispensing, restricted distribution requirements, dispensing only under certain circumstances
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
and effort in the areas of training, record keeping, production and quality control.
After the FDA evaluates the NDA and the manufacturing facilities … , but are not limited to, special training or certification for prescribing or dispensing, restricted distribution requirements, dispensing only under certain
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
Planning
General. The Board shall be responsible for succession planning, including appointing, training and monitoring senior management.
CEO Succession
424B4
1wrqy0x
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
t26vj2xtus1in4
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
9tq0e h6769h6fy7f
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
0qkksnt
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
ev852
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
tk5ros 5gwc
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
EX-11.1
9mri3r1vub1egon5a
3 May 22
Annual report (foreign)
5:29pm
20-F
dopa 0jf97e
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.23
alg9xa 8dy621
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
ghvulbga
23 Nov 21
XORTX Therapeutics Announces Annual and Special Meeting of Shareholders
7:21am
424B4
3a80r1szuq9 1z
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
sfkeo 2lw
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
ba3p4x
16 Sep 21
Registration statement (foreign) (amended)
5:16pm